Precision Biosciences (DTIL) Non-Current Deffered Revenue (2018 - 2025)
Precision Biosciences (DTIL) recorded Non-Current Deffered Revenue of $19.96 million in fiscal Q3 2025 (quarter ended Sep 30, 2025), down 24.9% from $26.58 million a year earlier and down 1.3% from the prior quarter.
Powered by 
Analysis
Precision Biosciences (DTIL) Non-Current Deffered Revenue (2018 - 2025) Analysis & Trends
At the end of FY2024 (ended Dec 31, 2024), Precision Biosciences reported Non-Current Deffered Revenue of $23.3 million, down 68.1% from FY2023.
- Annual Non-Current Deffered Revenue has a five-year compound annual growth rate of -18.8% (FY2019 to FY2024).
- Across earlier fiscal years, Non-Current Deffered Revenue came in at $73.08 million in FY2023 (-11.8%), $82.87 million in FY2022 (+23.7%), $67.02 million in FY2021 (+24.3%) and $53.93 million in FY2020 (-18.2%).
- The fiscal Q3 2025 figure is the lowest quarterly Non-Current Deffered Revenue in data going back to fiscal Q4 2018.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for ten consecutive quarters, with an average decline of 42.7% over the last eight quarters.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 99.0% in fiscal Q1 2021, against a decline of 72.6% in fiscal Q1 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $20.23 million (Q2 2025), $20.5 million (Q1 2025) and $23.3 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Precision Biosciences | 167.32 Mn | -181.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 19.96 Mn |
| Jun 30, 2025 | 20.23 Mn |
| Mar 31, 2025 | 20.50 Mn |
| Dec 31, 2024 | 23.30 Mn |
| Sep 30, 2024 | 26.58 Mn |
| Jun 30, 2024 | 26.78 Mn |
| Mar 31, 2024 | 74.77 Mn |
| Dec 31, 2023 | 73.08 Mn |
| Sep 30, 2023 | 73.90 Mn |
| Jun 30, 2023 | 78.08 Mn |
| Mar 31, 2023 | 82.76 Mn |
| Dec 31, 2022 | 82.87 Mn |
| Sep 30, 2022 | 90.51 Mn |
| Jun 30, 2022 | 104.05 Mn |
| Mar 31, 2022 | 65.74 Mn |
| Dec 31, 2021 | 67.02 Mn |
| Sep 30, 2021 | 71.84 Mn |
| Jun 30, 2021 | 75.30 Mn |
| Mar 31, 2021 | 131.24 Mn |
| Dec 31, 2020 | 53.93 Mn |
API Access
Precision Biosciences Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=DTIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "DTIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=DTIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();